• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Pharmaceutical Market
    Pharmaceutical News
    Pharmaceutical Stocks
    • Pharmaceutical Market
    • Pharmaceutical News
    • Pharmaceutical Stocks
    pharmaceutical investing

    CorMedix Announces Changes to Board of Directors

    Bryan Mc Govern
    Jun. 12, 2017 08:41AM PST
    Pharmaceutical Investing

    CorMedix announced changes to its board of directors in the upcoming weeks.

    CorMedix (NYSEMKT:CRMD) announced changes to its board of directors in the upcoming weeks.
    As quoted in the press release:

    These changes result from a constructive dialogue among the board, management and interested shareholders who have expressed dissatisfaction with a number of areas, including the recent financing. The changes are intended to help ensure the long-term success of the Company.
    Effective immediately, Cora Tellez has resigned her position as Board Chair and as a member of the Board. Ms. Tellez joined the Board in April 2014, and was elected Chair in May 2014. In addition, the Company announced that Michael George has agreed to resign his position as a member of the Board, to be effective as of the date on which the Board appoints the two new members who will backfill Ms. Tellez’s resignation and the contemplated resignation of Mr. George, respectively. Mr. George has served as a Director for CorMedix since February 2014.

    Click here to read the full press release.

    Source: www.accesswire.com

    pharmaceutical investingnyse:mktboard of directors
    The Conversation (0)

    Go Deeper

    AI Powered
    Lilly announces two new Executive Committee members and expansion of leadership roles to prepare for next wave of growth

    Lilly announces two new Executive Committee members and expansion of leadership roles to prepare for next wave of growth

    Concerned Shareholder of LevelJump Healthcare Corp. Requisitions Shareholder Meeting to Address Necessary Leadership Changes

    Concerned Shareholder of LevelJump Healthcare Corp. Requisitions Shareholder Meeting to Address Necessary Leadership Changes

    Latest News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Pharmaceutical Investing Stocks

    InMed Pharmaceuticals

    InMed Pharmaceuticals (INM)
    INM

    Cardiol Therapeutics

    Cardiol Therapeutics (CRDL:CC)
    CRDL:CC

    Invion Limited

    Invion Limited (IVX:AU)
    IVX:AU

    Principal Technologies

    Principal Technologies (PTEC:CC)
    PTEC:CC
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES